UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Strategy Inc
MSTR
|
+$1.21B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$855M |
| 3 |
Microsoft
MSFT
|
+$810M |
| 4 |
Advanced Micro Devices
AMD
|
+$805M |
| 5 |
Boeing
BA
|
+$739M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$561M |
| 2 |
Amneal Pharmaceuticals
AMRX
|
+$169M |
| 3 |
Eli Lilly
LLY
|
+$161M |
| 4 |
Unity
U
|
+$158M |
| 5 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.49% |
| 2 | Financials | 9.06% |
| 3 | Consumer Discretionary | 7.01% |
| 4 | Healthcare | 6.25% |
| 5 | Industrials | 6.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5601
Pyxis Oncology
PYXS
$236M
| $697K | ﹤0.01% |
446,699
+418,597
| +1,490% | +$1.21M |
|
|
LEO
5602
BNY Mellon Strategic Municipals
LEO
$387M
| $695K | ﹤0.01% |
115,104
-12,034
| -9% | -$75.9K |
|
5603
PUT
iQIYI
IQ
$1.28B
| $692K | ﹤0.01% |
344,300
-369,600
| -52% | -$876K |
|
5604
Gyre Therapeutics
GYRE
$744M
| $691K | ﹤0.01% |
57,084
+53,441
| +1,467% | +$684K |
|
5605
PUT
e.l.f. Beauty
ELF
$5.81B
| $691K | ﹤0.01% |
5,500
+5,300
| +2,650% | +$636K |
|
5606
TAT Technologies
TATT
$515M
| $690K | ﹤0.01% |
26,865
+26,714
| +17,691% | +$568K |
|
5607
iShares MSCI China Small-Cap ETF
ECNS
$66.4M
| $689K | ﹤0.01% |
26,992
+12,284
| +84% | +$329K |
|
5608
Invesco Dorsey Wright Utilities Momentum ETF
PUI
$54.4M
| $686K | ﹤0.01% |
17,740
+8,355
| +89% | +$337K |
|
5609
OrthoPediatrics
KIDS
$595M
| $686K | ﹤0.01% |
29,607
+21,602
| +270% | +$540K |
|
|
KTF
5610
DWS Municipal Income Trust
KTF
$352M
| $686K | ﹤0.01% |
72,565
-702
| -1% | -$6.94K |
|
5611
Xperi
XPER
$348M
| $686K | ﹤0.01% |
66,750
-13,418
| -17% | -$125K |
|
5612
Chegg
CHGG
$102M
| $685K | ﹤0.01% |
425,477
+319,814
| +303% | +$589K |
|
5613
Tenaya Therapeutics
TNYA
$163M
| $684K | ﹤0.01% |
478,508
+452,370
| +1,731% | +$1.01M |
|
|
EDD
5614
Morgan Stanley Emerging Markets Domestic Debt Fund
EDD
$385M
| $683K | ﹤0.01% |
150,472
-2,179
| -1% | -$10.3K |
|
5615
Martin Midstream Partners
MMLP
$95.9M
| $682K | ﹤0.01% |
190,005
+134,428
| +242% | +$532K |
|
|
BTC
5616
Grayscale Bitcoin Mini Trust ETF
BTC
$3.44B
| $682K | ﹤0.01% |
+16,284
| New | +$599K |
|
5617
BRC Group Holdings
RILY
$289M
| $682K | ﹤0.01% |
148,537
+28,985
| +24% | +$151K |
|
5618
ALX Oncology
ALXO
$290M
| $681K | ﹤0.01% |
408,056
+378,816
| +1,296% | +$582K |
|
|
DSM
5619
BNY Mellon Strategic Municipal Bond Fund
DSM
$293M
| $680K | ﹤0.01% |
117,059
-5,145
| -4% | -$31.1K |
|
5620
Nuveen New York Quality Municipal Income Fund
NAN
$373M
| $680K | ﹤0.01% |
59,608
+5,298
| +10% | +$61.2K |
|
|
BBUC
5621
Brookfield Business Corp Class A Subordinate Voting Shares
BBUC
$6.04B
| $679K | ﹤0.01% |
27,980
+9,511
| +51% | +$243K |
|
5622
X4 Pharmaceuticals
XFOR
$460M
| $678K | ﹤0.01% |
30,769
+22,065
| +254% | +$352K |
|
5623
Global X MSCI Norway ETF
NORW
$86.1M
| $675K | ﹤0.01% |
28,763
-2,921
| -9% | -$73.2K |
|
5624
Global X Cybersecurity ETF
BUG
$1.46B
| $672K | ﹤0.01% |
20,956
+3,564
| +20% | +$116K |
|
5625
GrafTech
EAF
$212M
| $672K | ﹤0.01% |
38,845
+22,725
| +141% | +$423K |
|
Similar funds
UBS Group's Q4 2024 Portfolio in Review
As of Q4 2024, UBS Group held 10,816 positions worth $541B, up 18% from $459B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
UBS Group deployed $80.6B of net new capital in Q4 2024, opening 1,382 new positions and adding to 6,044 existing holdings. Its largest new stake was Primo Brands: 1,234,826 shares worth $38M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was UnitedHealth, an estimated $561M trimmed.
- UBS Group's largest Q4 2024 buy was Primo Brands: 1,234,826 shares worth $38M.
- UBS Group added most to Strategy Inc in Q4 2024, an estimated $1.21B increase.
- UBS Group's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $561M.
- UBS Group fully exited CATALENT, INC. in Q4 2024, selling an estimated $86M.
- UBS Group's ten largest holdings make up 16% of its $541B portfolio in Q4 2024.
- UBS Group opened 1,382 new positions and closed 943 in Q4 2024.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $541B.
Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.